SALE PROSPECTUS

Greater Eastern Obesity Surgery (GEOS)

Melbourne, Victoria Prepared August 2026

- Executive Summary

Greater Eastern Obesity Surgery (GEOS) is a boutique, highly specialised metabolic and bariatric surgery service operating in Melbourne’s South-East. Established over two decades ago, GEOS has built a reputation for exceptional governance, meticulous clinical pathways, and safe, high-quality outcomes across gastric banding, sleeve gastrectomy, and revisional bariatric surgery.

Although GEOS currently receives 5–7 new referrals per year, the practice maintains a high-acuity patient cohort, a stable revision pipeline, and a fully developed digital and clinical infrastructure that can be seamlessly integrated into a larger bariatric organization, or to start a surgeons new practice.

The proposed sale includes all digital assets, referral pathways, clinical protocols, and the GEOS brand, enabling the buyer to absorb GEOS patients into their existing service while expanding their digital footprint and strengthening their presence in Melbourne’s South-East.

The asking price of $30,000 negotiable, reflects the value of GEOS’s strategic assets and offsets the seller’s ongoing indemnity obligations for historical bariatric activity.

- Strategic Value Proposition

GEOS offers a buyer strategic value, not volume. The practice is uniquely positioned as a clean, low-risk, high-governance metabolic surgery brand with assets that can be immediately deployed within a larger bariatric ecosystem.

Key strategic advantages

- Boutique brand with high trust GEOS is known for careful patient selection, safe outcomes, and long-term follow-up.
- High-acuity patient cohort Current referrals include complex metabolic cases, revision candidates, and long-term follow-up patients — ideal for a high-volume centre seeking higher-value cases.
- Revision-friendly identity GEOS has a long history of band removals, sleeve revisions, and reflux-driven conversions.
- GLP 1–integrated model GEOS incorporates modern obesity pharmacotherapy into pre- and post-operative pathways, aligning with 2026–2030 market realities.
- Fully transferable digital ecosystem Includes website, domain, hosting (paid to 2028), SEO footprint, patient education content, and referral funnels.
- Structured multidisciplinary pathways Dietetics, psychology, physician-led metabolic optimisation, and telehealth follow-up — all documented and ready for integration.




- Clean medico-legal profile No bariatric-related claims. Strong governance. Registry participation. “Valued Contributor” status.
- Turnkey acquisition No staff liabilities, no operational complexity, no legacy complications — a rare asset in bariatric surgery.
- Clinical Profile

Services historically provided

- Gastric banding (legacy cohort)
- Sleeve gastrectomy
- Revisional bariatric surgery o Band → Sleeve o Band → Bypass o Sleeve → Bypass o Reflux-driven conversions
- Long-term metabolic follow-up
- GLP 1–integrated obesity management

Current referral profile (2024–2026)
- 5–7 new referrals/year
- High BMI, high comorbidity
- Diabetes, OSA, severe reflux
- Patients who have trialled GLP 1 therapy
- Revision candidates
- Long-term follow-up patients requiring surveillance

Clinical governance

- Structured pre-operative pathway (3–6 months)
- Standardised consent and education modules
- Documented follow-up protocols
- Registry participation
- Zero bariatric claims over 20 years
- Digital & Operational Assets Included in the Sale

Digital assets

- geobesity.com.au domain
- Website content, structure, and SEO history
- Hosting prepaid through 2028
- Transferable passwords and backend access
- Patient education modules
- Referral forms and downloadable resources
- Online enquiry funnels

Clinical & operational assets
- Pre-operative pathway documentation
- Post-operative follow-up protocols
- Consent templates
- Patient information sheets
- Revision surgery guidelines
- GLP 1 integration pathway
- Clinical governance framework
- Registry participation history
- Branding and marketing collateral

Patient cohort

- Existing GEOS patients
- Long-term follow-up patients
- Patients requiring future revision
- Patients currently in work-up
- Patients who will transition to LSA or buyer’s service
- Market Context (2026–2030)

GLP 1 impact

Injectables have reduced low-BMI primary sleeve demand but increased:
- High-acuity surgical candidates
- Revision surgery
- Metabolic optimisation pathways
- Patients who fail or plateau on pharmacotherapy





GEOS is already aligned with this future: a boutique metabolic surgery service specialising in complex cases.

Melbourne bariatric landscape

- High density of private bariatric providers
- Increasing demand for revision and metabolic surgery
- Strong GP prescribing culture for GLP 1s
- Buyers seeking digital expansion and brand consolidation

GEOS offers exactly what the market lacks: a clean, transferable, high-governance brand with a revision-friendly identity.
- Transition Plan

GEOS will provide

- Full transfer of digital assets
- Full transfer of clinical documentation
- Structured handover of all active patients
- Referral redirection to buyer’s service
- Support for integration of GEOS pathways into buyer’s system
- Ongoing indemnity coverage for historical bariatric activity (funded by seller)

This ensures a smooth, low-risk, fully supported transition.
- Financial Considerations

Sale price: $30,000

This reflects

- The value of GEOS’s digital assets
- The value of its brand equity
- The value of its referral pathways
- The value of its clinical governance IP
- The value of its patient cohort
- The cost offset for the seller’s ongoing indemnity tail (approx. $20,000/year for 3 years)

Operating costs

GEOS currently operates with

- Minimal overhead
- No staff liabilities
- No lease obligations
- No equipment burden
- No outstanding debts

This makes GEOS a clean acquisition.
- Summary of Buyer Benefits

By acquiring GEOS, the buyer gains:
- Instant expansion into Melbourne’s South-East
- A respected metabolic surgery brand
- A revision-friendly patient cohort
- A GLP 1–aligned clinical model
- A fully developed digital presence
- A clean medico-legal history
- A turnkey set of clinical pathways
- A seamless patient transfer pipeline
- Zero operational risk

GEOS is a strategic bolt-on acquisition that strengthens the buyer’s brand, digital footprint, and metabolic surgery capability.

Conclusion

GEOS is a rare prospect: a clean, boutique, high-governance metabolic surgery brand with a fully transferable digital ecosystem, a revision-friendly identity, and a patient cohort that integrates seamlessly into a larger bariatric service or a new practice starting out.

In the GLP 1 era, GEOS represents exactly the kind of future-proof, high-acuity asset that major bariatric groups seek.

Interested Parties should call Ilanit M 0413-625-420 to discuss this opportunity further.

📌 Bariatric Surgeon to take over practice (Melbourne)
🏢 Monash Health
📍 Melbourne